Fresenius Forecast, price target & analysts
Fresenius Target price 2025 - Analyst rating & recommendation
Fresenius Classifications & Recommendation:
Fresenius Price Target
| Target Price | €50.49 |
| Price | €42.68 |
| Potential | 18.30% |
| Number of Estimates | 20 |
| 20 Analysts have issued a price target Fresenius 2026 . The average Fresenius target price is €50.49. This is 18.30% higher than the current stock price. The highest price target is €55.65 30.39% , the lowest is €42.42 0.61% . | |
| A rating was issued by 23 analysts: 19 Analysts recommend Fresenius to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Fresenius stock has an average upside potential 2026 of 18.30% . Most analysts recommend the Fresenius stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2031
21 Analysts have issued a sales forecast Fresenius 2025 . The average Fresenius sales estimate is €22.9b . This is 3.63% higher than the revenue of the last 12 months(TTM). The highest sales forecast is €24.1b 8.98% , the lowest is €22.0b 0.43% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | €21.8b | 3.64% |
|---|---|---|
| 2025 | €22.9b | 4.93% |
| 2026 | €24.1b | 5.03% |
| 2027 | €25.3b | 5.09% |
| 2028 | €26.4b | 4.23% |
| 2029 | €27.7b | 4.93% |
| 2030 | €27.8b | 0.56% |
| 2031 | €29.0b | 4.23% |
19 Analysts have issued an Fresenius EBITDA forecast 2025. The average Fresenius EBITDA estimate is €3.8b . This is 94.22% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €4.1b 109.21% , the lowest is €3.3b 71.15% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | €1.8b | 43.32% |
|---|---|---|
| 2025 | €3.8b | 108.28% |
| 2026 | €4.1b | 8.35% |
| 2027 | €4.4b | 5.74% |
| 2028 | €4.6b | 4.96% |
| 2029 | €4.8b | 4.84% |
EBITDA Margin
| 2024 | 8.35% | 38.29% |
|---|---|---|
| 2025 | 16.57% | 98.45% |
| 2026 | 17.10% | 3.20% |
| 2027 | 17.20% | 0.58% |
| 2028 | 17.32% | 0.70% |
| 2029 | 17.31% | 0.06% |
21 Fresenius Analysts have issued a net profit forecast 2025. The average Fresenius net profit estimate is €1.9b . This is 342.29% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.1b 403.25% , the lowest is €1.3b 203.45% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | €471m | 179.29% |
|---|---|---|
| 2025 | €1.9b | 296.28% |
| 2026 | €2.1b | 11.84% |
| 2027 | €2.3b | 7.82% |
| 2028 | €2.5b | 10.69% |
| 2029 | €2.6b | 4.59% |
| 2030 | €2.8b | 5.75% |
Net Margin
| 2024 | 2.16% | 176.51% |
|---|---|---|
| 2025 | 8.15% | 277.79% |
| 2026 | 8.68% | 6.50% |
| 2027 | 8.90% | 2.53% |
| 2028 | 9.45% | 6.18% |
| 2029 | 9.42% | 0.32% |
| 2030 | 9.91% | 5.20% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2031
21 Analysts have issued a Fresenius forecast for earnings per share. The average Fresenius EPS is €3.31 . This is 347.30% higher than earnings per share in the financial year 2024. The highest EPS forecast is €3.77 409.46% , the lowest is €2.27 206.76% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | €0.83 | 179.05% |
|---|---|---|
| 2025 | €3.31 | 298.80% |
| 2026 | €3.71 | 12.08% |
| 2027 | €4.00 | 7.82% |
| 2028 | €4.42 | 10.50% |
| 2029 | €4.63 | 4.75% |
| 2030 | €4.89 | 5.62% |
P/E ratio
| Current | 57.55 | 214.82% |
|---|---|---|
| 2025 | 12.85 | 77.67% |
| 2026 | 11.49 | 10.58% |
| 2027 | 10.66 | 7.22% |
| 2028 | 9.48 | 11.07% |
| 2029 | 9.07 | 4.32% |
| 2030 | 8.71 | 3.97% |
Based on analysts' sales estimates for 2025, the Fresenius stock is valued at an EV/Sales of 1.45 and an P/S ratio of 1.03 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 1.50 | 41.51% |
|---|---|---|
| 2025 | 1.45 | 3.43% |
| 2026 | 1.38 | 4.80% |
| 2027 | 1.31 | 4.84% |
| 2028 | 1.26 | 3.95% |
| 2029 | 1.20 | 4.70% |
| 2030 | 1.19 | 0.68% |
| 2031 | 1.14 | 4.06% |
P/S ratio
| Current | 1.06 | 86.13% |
|---|---|---|
| 2025 | 1.03 | 3.51% |
| 2026 | 0.98 | 4.79% |
| 2027 | 0.93 | 4.84% |
| 2028 | 0.89 | 3.90% |
| 2029 | 0.85 | 4.71% |
| 2030 | 0.85 | 0.72% |
| 2031 | 0.81 | 4.07% |
Current Fresenius Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BERENBERG |
Buy
➜
Buy
|
Unchanged | Mar 31 2025 |
| DAY BY DAY |
Hold
➜
Buy
|
Upgrade | Mar 23 2025 |
| HSBC |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
| JEFFERIES |
Buy
➜
Buy
|
Unchanged | Mar 20 2025 |
| METZLER EQUITIES |
Buy
➜
Buy
|
Unchanged | Mar 18 2025 |
| DZ BANK |
Buy
➜
Buy
|
Unchanged | Mar 16 2025 |
| WARBURG RESEARCH GMBH |
Buy
➜
Buy
|
Unchanged | Mar 03 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
BERENBERG:
Buy
➜
Buy
|
Mar 31 2025 |
|
Upgrade
DAY BY DAY:
Hold
➜
Buy
|
Mar 23 2025 |
|
Unchanged
HSBC:
Buy
➜
Buy
|
Mar 23 2025 |
|
Unchanged
JEFFERIES:
Buy
➜
Buy
|
Mar 20 2025 |
|
Unchanged
METZLER EQUITIES:
Buy
➜
Buy
|
Mar 18 2025 |
|
Unchanged
DZ BANK:
Buy
➜
Buy
|
Mar 16 2025 |
|
Unchanged
WARBURG RESEARCH GMBH:
Buy
➜
Buy
|
Mar 03 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
